drugset / Trial / NCT06031961
The Premedication Properties of Oral Melatonin in Pediatrics Undergoing Therapeutic Cardiac Catheterization
RandomizedParallel-groupTriple-blindTreatment
Summary
The evaluation of oral melatonin efficacy as premedicant agent in pediatrics undergoing elective cardiac interventions is the primary outcomes of our trail.
Timeline
- Start
- 2023-09-10
- Primary completion
- 2024-05-15
- Completion
- 2024-08-15
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Melatonin | Small molecule | 0.5 mg/kg | Oral |
Indications
No indication recorded.